Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IFM2008: VRD in De Novo Multiple Myeloma
NCT01206205Phase 2Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Aug 2009
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in multiple myeloma (MM), sponsored by Centre hospitalier universitaire de Toulouse. Started Aug 2009; status: completed.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01206205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01206205.